SS
KMTS

Steve Schonfeld’s Kestra Medical Technologies KMTS Stock Holding History

Steve Schonfeld’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.28M Buy
286,231
+172,368
+151% +$3.61M 0.03% 513
2026
Q1 		$2.27M Buy
+113,863
New +$2.68M 0.02% 769
2025
Q3 		– Sell
-71,074
Closed -$1.18M – 2674
2025
Q2 		$1.18M Buy
71,074
+36,110
+103% +$788K 0.01% 1234
2025
Q1 		$871K Buy
+34,964
New +$803K 0.01% 1344

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Steve Schonfeld's KMTS Position: Q2 2026 in Review

Steve Schonfeld increased its Kestra Medical Technologies (KMTS) stake by 151% in Q2 2026, buying an estimated $3.61M and bringing the position to 286,231 shares worth $7.28M. The position accounts for 0.03% of the portfolio, ranked #513.

Steve Schonfeld first reported a position in KMTS in Q1 2025 and has held it in 4 quarters since. 108 funds tracked by Wall St. Rank hold KMTS as of Q2 2026.

  • Steve Schonfeld held 286,231 shares of Kestra Medical Technologies worth $7.28M as of Q2 2026.
  • Steve Schonfeld bought 172,368 Kestra Medical Technologies shares in Q2 2026, an estimated $3.61M.
  • Kestra Medical Technologies made up 0.03% of Steve Schonfeld's portfolio in Q2 2026, its #513 holding.
  • Steve Schonfeld first reported a position in Kestra Medical Technologies in Q1 2025 and has held it in 4 quarters since.
  • 108 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.